Key result
A 45-year-old female patient experienced fatal complications following percutaneous pulmonary valve implantation due to valve migration, emphasizing the need for prompt cardiac surgery support.
Why the study?
Although PPVI is largely considered safe, life-threatening complications can occur that require immediate and adequate institutional management.
Case Report (n=1)
No
This case highlights the risk of life-threatening complications such as valve migration during percutaneous pulmonary valve implantation, emphasizing the critical need for immediate on-site cardiac surgery support.
Answers are grounded in this paper and cite their sources.
Fatal valve migration in PPVI warrants on-site surgical readiness; this case leaves open optimal patient selection and prevention.
Pulmonary valve dysfunction, also called right ventricle outflow tract dysfunction, is one of the known anomalies in patients with congenital heart disease. Percutaneous pulmonary valve implantation (PPVI) has been developed as an alternative to surgical correction. Although it is largely considered a safe procedure, life-threatening complications can happen and institutions must be able to resolve these immediately and adequately. We present a case of pulmonary valve migration to the right ventricle during a PPVI. This complication needed immediate cardiac surgery due to resulting hemodynamic instability. The percutaneous valve prosthesis was removed and a bioprosthetic valve was surgically implanted in the correct position. This case emphasizes the need of prompt cardiac surgery support and the readiness of the anesthesia team to deal with emergency open cardiac surgery. Citation: Sampaio A, Norte G, Godinho L, Raimundo A, Cuervo M. A case report of a complicated fatal percutaneous valve implantation. Anaesth pain & intensive care 2019;23(4)__ Received: 24 September 2019, Reviewed: 24, 26 October 2019, Accepted: 22 November 2019
No takes yet. Share an insight, caveat, or question.
Sampaio et al. (2020) conducted a case report in Pulmonary valve dysfunction (n=1). Percutaneous pulmonary valve implantation (PPVI) was evaluated. A 45-year-old female patient experienced fatal complications following percutaneous pulmonary valve implantation due to valve migration, emphasizing the need for prompt cardiac surgery support.
Synapse has enriched 10 related papers. Consider them for comparative context: